Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
Almost all pharmaceuticals are driven by the cost of drug discovery and studies. You want the cost of drugs to be enough to drive investment into new drugs, but not so much that it becomes impractical for people to afford.
I mean yeah, the entire point is to maximize profit.
I was just curious if this was an inflated price due to “intellectual property rights” associated with the drug, which it appears to be.
I wonder how much it costs to actually manufacture. I feel like more people should understand that before they accept paying $8k or even $800 for a drug.
Almost all pharmaceuticals are driven by the cost of drug discovery and studies. You want the cost of drugs to be enough to drive investment into new drugs, but not so much that it becomes impractical for people to afford.
I mean yeah, the entire point is to maximize profit.
I was just curious if this was an inflated price due to “intellectual property rights” associated with the drug, which it appears to be.
I wonder how much it costs to actually manufacture. I feel like more people should understand that before they accept paying $8k or even $800 for a drug.
Junshi owns the IP and is licensing it out to Coherus.